Literature DB >> 3621288

Osteoclast generation from human fetal bone marrow in cocultures with murine fetal long bones. A model for in vitro study of human osteoclast formation and function.

M H Helfrich, C W Thesingh, R H Mieremet, A S van Iperen-van Gent.   

Abstract

Osteoclast formation in vitro from human progenitor cells was studied in cocultures of periosteum-free murine long-bone rudiments and human fetal tissues. No osteoclasts were generated from chorionic villi or from fetal liver, but bone marrow and purified bone-marrow fractions gave rise to multinucleated cells that resorbed calcified cartilage matrix. These polykarya react very strongly for tartrate-resistant acid phosphatase (TrAP) and upon ultrastructural examination show large ruffled borders in areas of resorption. Resorption of murine calcified cartilage matrix by human osteoclasts was less than resorption. by osteoclasts formed from murine fetal bone-marrow cells. Our results show that the murine long-bone rudiment can be used to generate osteoclasts from human sources of progenitor cells and to assess the biological activity of the formed osteoclasts. This coculture system thereby offers possibilities to study human osteoclast pathology in vitro. The use of TrAP as marker for osteoclasts in cell cultures is discussed.

Entities:  

Mesh:

Year:  1987        PMID: 3621288     DOI: 10.1007/bf00215426

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  31 in total

Review 1.  The origin of osteoclasts: evidence, clinical implications and investigative challenges of an extra-skeletal source.

Authors:  S C Marks
Journal:  J Oral Pathol       Date:  1983-08

2.  Mononuclear phagocytes in the human placenta.

Authors:  G W Wood
Journal:  Placenta       Date:  1980 Apr-Jun       Impact factor: 3.481

3.  Contact-mediated bone resorption by human monocytes in vitro.

Authors:  A J Kahn; C C Stewart; S L Teitelbaum
Journal:  Science       Date:  1978-03-03       Impact factor: 47.728

4.  Demonstration of tartrate-resistant acid phosphatase in un-decalcified, glycolmethacrylate-embedded mouse bone: a possible marker for (pre)osteoclast identification.

Authors:  F P van de Wijngaert; E H Burger
Journal:  J Histochem Cytochem       Date:  1986-10       Impact factor: 2.479

5.  The resorption of biological and non-biological substrates by cultured avian and mammalian osteoclasts.

Authors:  S J Jones; A Boyde; N N Ali
Journal:  Anat Embryol (Berl)       Date:  1984

6.  Cell surface characterization of the human osteoclast: phenotypic relationship to other bone marrow-derived cell types.

Authors:  M A Horton; E F Rimmer; D Lewis; J A Pringle; K Fuller; T J Chambers
Journal:  J Pathol       Date:  1984-12       Impact factor: 7.996

7.  Human fetal osteoclasts fail to express macrophage antigens.

Authors:  M A Horton; D Lewis; K McNulty; J A Pringle; T J Chambers
Journal:  Br J Exp Pathol       Date:  1985-02

8.  Interleukin 3 promotes the in vitro proliferation of murine pluripotent hematopoietic stem cells.

Authors:  J L Spivak; R R Smith; J N Ihle
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

9.  Immunocytochemical identification of cytotrophoblast from other mononuclear cell populations isolated from first-trimester human chorionic villi.

Authors:  B H Butterworth; Y W Loke
Journal:  J Cell Sci       Date:  1985-06       Impact factor: 5.285

10.  The origin, kinetics, and characteristics of the Kupffer cells in the normal steady state.

Authors:  R W Crofton; M M Diesselhoff-den Dulk; R van Furth
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

View more
  9 in total

1.  Osteoclasts and a small population of peripheral blood cells share common surface antigens.

Authors:  T A Hentunen; J Tuukkanen; H K Väänänen
Journal:  Calcif Tissue Int       Date:  1990-07       Impact factor: 4.333

2.  Suppression of osteoclastogenesis through phosphorylation of eukaryotic translation initiation factor 2 alpha.

Authors:  Kazunori Hamamura; Nancy Tanjung; Hiroki Yokota
Journal:  J Bone Miner Metab       Date:  2013-03-28       Impact factor: 2.626

3.  In vitro method for the screening and monitoring of estrogen-deficiency osteoporosis by targeting peripheral circulating monocytes.

Authors:  Francesca Salamanna; Melania Maglio; Gianluca Giavaresi; Stefania Pagani; Roberto Giardino; Milena Fini
Journal:  Age (Dordr)       Date:  2015-08-07

4.  Purification and characterization of a tartrate-resistant acid phosphatase from human osteoclastomas.

Authors:  A R Hayman; M J Warburton; J A Pringle; B Coles; T J Chambers
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

5.  Using a novel microRNA delivery system to inhibit osteoclastogenesis.

Authors:  Yanlan Yao; Tingting Jia; Yang Pan; Hongna Gou; Yulong Li; Yu Sun; Rui Zhang; Kuo Zhang; Guigao Lin; Jiehong Xie; Jinming Li; Lunan Wang
Journal:  Int J Mol Sci       Date:  2015-04-14       Impact factor: 5.923

6.  The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling.

Authors:  Hiroyuki Kanzaki; Fumiaki Shinohara; Mikihito Kajiya; Tetsuya Kodama
Journal:  J Biol Chem       Date:  2013-06-25       Impact factor: 5.157

Review 7.  Postmenopausal osteoporosis: the role of immune system cells.

Authors:  Maria Felicia Faienza; Annamaria Ventura; Flaviana Marzano; Luciano Cavallo
Journal:  Clin Dev Immunol       Date:  2013-05-23

Review 8.  The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis.

Authors:  M Neale Weitzmann
Journal:  Scientifica (Cairo)       Date:  2013-02-03

9.  Loss of p53 in mesenchymal stem cells promotes alteration of bone remodeling through negative regulation of osteoprotegerin.

Authors:  Tania Velletri; Yin Huang; Yu Wang; Qing Li; Mingyuan Hu; Ningxia Xie; Qian Yang; Xiaodong Chen; Qing Chen; Peishun Shou; Yurun Gan; Eleonora Candi; Margherita Annicchiarico-Petruzzelli; Massimiliano Agostini; Huilin Yang; Gerry Melino; Yufang Shi; Ying Wang
Journal:  Cell Death Differ       Date:  2020-07-21       Impact factor: 15.828

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.